Therapies for Retinal Diseases (Everads / VivaVision Biopharma) Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

Therapies for Retinal Diseases (Everads / VivaVision Biopharma) General Information

Description

Developer of therapeutic remedies for retinal diseases. The company will offer retinal therapies by leveraging its novel suprachoroidal delivery technology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Tel Aviv
  • Israel
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Healthcare Services
Corporate Office
  • Tel Aviv
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Therapies for Retinal Diseases (Everads / VivaVision Biopharma) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Therapies for Retinal Diseases (Everads / VivaVision Biopharma)‘s full profile, request access.

Request a free trial

Therapies for Retinal Diseases (Everads / VivaVision Biopharma) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Therapies for Retinal Diseases (Everads / VivaVision Biopharma)‘s full profile, request access.

Request a free trial

Therapies for Retinal Diseases (Everads / VivaVision Biopharma) FAQs

  • When was Therapies for Retinal Diseases (Everads / VivaVision Biopharma) founded?

    Therapies for Retinal Diseases (Everads / VivaVision Biopharma) was founded in 2023.

  • Where is Therapies for Retinal Diseases (Everads / VivaVision Biopharma) headquartered?

    Therapies for Retinal Diseases (Everads / VivaVision Biopharma) is headquartered in Tel Aviv, Israel.

  • What industry is Therapies for Retinal Diseases (Everads / VivaVision Biopharma) in?

    Therapies for Retinal Diseases (Everads / VivaVision Biopharma)’s primary industry is Drug Discovery.

  • Is Therapies for Retinal Diseases (Everads / VivaVision Biopharma) a private or public company?

    Therapies for Retinal Diseases (Everads / VivaVision Biopharma) is a Private company.

  • What is Therapies for Retinal Diseases (Everads / VivaVision Biopharma)’s current revenue?

    The current revenue for Therapies for Retinal Diseases (Everads / VivaVision Biopharma) is .

  • Who are Therapies for Retinal Diseases (Everads / VivaVision Biopharma)’s investors?

    Everads and Viva Vision Biotech have invested in Therapies for Retinal Diseases (Everads / VivaVision Biopharma).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process